Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Medicine
Medicine publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 11-20 of 36 (Search time: 0.003 seconds).
previous
1
2
3
4
next
Item hits:
Preview
Issue Date
Title
Author(s)
2011
Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial
Kantarjian, H.
;
Hochhaus, A.
;
Saglio, G.
;
de Souza, C.
;
Flinn, I.
;
Stenke, L.
;
Goh, Y.
;
Rosti, G.
;
Nakamae, H.
;
Gallagher, N.
;
Hoenekopp, A.
;
Blakesley, R.
;
Larson, R.
;
Hughes, T.
2008
International standardisation of quantitative real-time RT-PCR for BCR-ABL
Cross, N.
;
Hughes, T.
;
Hochhaus, A.
;
Goldman, J.
2010
Practical considerations for monitoring patients with chronic myeloid leukemia
Branford, S.
;
Hughes, T.
2003
Molecular monitoring of chronic myeloid leukemia
Hughes, T.
;
Branford, S.
2003
Imatinib inhibits the in vitro development of the monocyte/macrophage lineage from normal human bone marrow progenitors
Dewar, A.
;
Domaschenz, R.
;
Doherty, K.
;
Hughes, T.
;
Lyons, A.
2003
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia
Hughes, T.
;
Kaeda, J.
;
Branford, S.
;
Rudzki, Z.
;
Hochhaus, A.
;
Hensley, M.
;
Gathmann, I.
;
Bolton, A.
;
van Hoomissen, I.
;
Goldman, J.
;
Radich, J.
2008
BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
Mullighan, C.
;
Miller, C.
;
Radtke, I.
;
Philips, L.
;
Dalton, J.
;
Ma, J.
;
White, D.
;
Hughes, T.
;
Le Beau, M.
;
Pui, C.
;
Relling, M.
;
Shurtleff, S.
;
Downing, J.
2002
Dual transcription of b2a2 and b3a2 BCR-ABL transcripts in chronic myeloid leukaemia is confined to patients with a linked polymorphism within the BCR gene
Branford, S.
;
Hughes, T.
;
Rudzki, Z.
2010
Nilotinib versus Imatinib for newly diagnosed chronic myeloid leukemia
Saglio, G.
;
Kim, D.
;
Issaragrisil, S.
;
le Coutre, P.
;
Etienne, G.
;
Lobo, C.
;
Pasquini, R.
;
Clark, R.
;
Hochhaus, A.
;
Hughes, T.
;
Gallagher, N.
;
Hoenekopp, A.
;
Haque, A.
;
Dong, M.
;
Larson, R.
;
Kantarjian, H.
2004
Clinical resistance to imatinib: mechanisms and implications
Hochhaus, A.
;
Hughes, T.
Discover
Author
18
Branford, S.
13
Hochhaus, A.
6
Cortes, J.
6
Kantarjian, H.
6
Kim, D.
6
Radich, J.
6
Saglio, G.
6
White, D.
5
Larson, R.
5
Ross, D.
.
next >
Subject
27
Leukemia, Myelogenous, Chronic, B...
25
Pyrimidines
23
Imatinib Mesylate
23
Piperazines
22
Benzamides
19
Antineoplastic Agents
11
Male
11
Protein Kinase Inhibitors
9
Female
9
Mutation
.
next >
Date issued
16
2010 - 2017
20
2000 - 2009